
|Articles|February 23, 2007
Oncolytics Biotech Appoints Vice President, IP
Author(s)BioPharm International Editors
Oncolytics Biotech (Calgary, Canada, www.oncolyticsbiotech.com) has appointed Mary Ann Dillahunty as VP, Intellectual Property.
Advertisement
Oncolytics Biotech (Calgary, Canada,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
2
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
3
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5




